KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Current Taxes (2016 - 2025)

Historic Current Taxes for Pfizer (PFE) over the last 17 years, with Q3 2025 value amounting to $3.8 billion.

  • Pfizer's Current Taxes rose 3204.73% to $3.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.8 billion, marking a year-over-year increase of 3204.73%. This contributed to the annual value of $2.9 billion for FY2024, which is 2388.25% up from last year.
  • According to the latest figures from Q3 2025, Pfizer's Current Taxes is $3.8 billion, which was up 3204.73% from $3.7 billion recorded in Q2 2025.
  • Over the past 5 years, Pfizer's Current Taxes peaked at $4.5 billion during Q4 2021, and registered a low of $1.3 billion during Q4 2021.
  • For the 5-year period, Pfizer's Current Taxes averaged around $2.7 billion, with its median value being $2.9 billion (2024).
  • As far as peak fluctuations go, Pfizer's Current Taxes soared by 21440.56% in 2021, and later crashed by 3819.6% in 2023.
  • Quarter analysis of 5 years shows Pfizer's Current Taxes stood at $1.3 billion in 2021, then rose by 25.36% to $1.6 billion in 2022, then surged by 48.02% to $2.3 billion in 2023, then increased by 23.88% to $2.9 billion in 2024, then skyrocketed by 30.55% to $3.8 billion in 2025.
  • Its last three reported values are $3.8 billion in Q3 2025, $3.7 billion for Q2 2025, and $3.1 billion during Q1 2025.